ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Basic/Clinical Science Session

Clinical Trials in Pediatric CKD: Trial with SGLT2 Inhibitors?

November 02, 2023 | 02:00 PM - 04:00 PM

Location: Room 108, Pennsylvania Convention Center

Session Description

SGLT2 inhibitors are a class of drugs that have recently been shown to be effective in slowing the progression of kidney diseases in adults with and without diabetes. The majority of clinical trials have been conducted in adults. This session focuses on the outcomes of clinical trials in adults, as well as obstacles in designing a pediatric clinical trial and a conceptual model for a trial in children. A family's perspective on CKD is also shared.

ASN thanks the Kidney Health Initiative for assistance with this session.

Learning Objective(s)

  • Describe the effects of SGLT2 inhibitors on the kidneys and the outcomes of clinical trials in adults thus far
  • Summarize the various hurdles involved in designing and implementing clinical trials in pediatrics and available solutions
  • Develop a conceptual model for a pediatric clinical trial
  • Explore a family's perspective on CKD

Learning Pathway(s)

  • Pediatric Nephrology
  • CKD Non-Dialysis